Daiichi Sankyo | 4568 - Cash And Equivalent


Daiichi Sankyo reported JPY542.16B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Astellas Pharma JPY 188.37B 8.51B Mar/2025
Chugai Pharma JPY 426.6B 29.83B Dec/2025
Daiichi Sankyo JPY 542.16B 97.68B Sep/2025
Eisai JPY 301.65B 16.27B Sep/2025
Kyowa Hakko Kirin JPY 218.77B 15.83B Dec/2025
M3 JPY 133.85B 1.09B Sep/2025
Otsuka Holdings JPY 534.64B 123.53B Dec/2025
Shionogi JPY 233.86B 20.96B Sep/2025
Sumitomo Dainippon JPY 38.49B 15.37B Sep/2025
Takeda JPY 654.94B 26.55B Dec/2025
Terumo JPY 217.16B 12.86B Sep/2025